Literature DB >> 8173313

[Compatibility problems in intensive care medicine].

F Schröder1.   

Abstract

OBJECTIVE: This review outlines the risk of incompatibility reactions due to the simultaneous administration of total parenteral nutrition together with a variety of different drugs. DATA SOURCES: The actual medical literature and results from own studies where used.
RESULTS: Besides well-known reactions between the different electrolytes, the different pH and pka value leads to incompatibility with side effects and loss of drug effectiveness. Apart from restrictive medication, the use of a multi-lumen catheter and the use of PC programs may help to avoid these reactions.
CONCLUSIONS: Knowledge of incompatibility reactions in parenteral nutrition and infusion therapy is mandatory to avoid negative side effects.

Mesh:

Year:  1994        PMID: 8173313

Source DB:  PubMed          Journal:  Infusionsther Transfusionsmed        ISSN: 1019-8466


  3 in total

1.  In-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective, randomized, controlled trial.

Authors:  Thomas Jack; Martin Boehne; Bernadette E Brent; Ludwig Hoy; Harald Köditz; Armin Wessel; Michael Sasse
Journal:  Intensive Care Med       Date:  2012-04-12       Impact factor: 17.440

2.  In-line Filtration Decreases Systemic Inflammatory Response Syndrome, Renal and Hematologic Dysfunction in Pediatric Cardiac Intensive Care Patients.

Authors:  Michael Sasse; Friederike Dziuba; Thomas Jack; Harald Köditz; Torsten Kaussen; Harald Bertram; Philipp Beerbaum; Martin Boehne
Journal:  Pediatr Cardiol       Date:  2015-04-07       Impact factor: 1.655

3.  In-line filtration minimizes organ dysfunction: new aspects from a prospective, randomized, controlled trial.

Authors:  Martin Boehne; Thomas Jack; Harald Köditz; Kathrin Seidemann; Florian Schmidt; Michaela Abura; Harald Bertram; Michael Sasse
Journal:  BMC Pediatr       Date:  2013-02-06       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.